Mefloquine in the treatment of cutaneous leishmaniasis

Rev Soc Bras Med Trop. 1999 Sep-Oct;32(5):585. doi: 10.1590/s0037-86821999000500018.

Abstract

Three cases of cutaneous leishmaniasis were treated orally with a mefloquine dose of 4.2 mg/kg/day for six days in the Teaching Hospital of the Faculdade de Medicina do Triângulo Mineiro, Uberaba, MG, Brazil. Three weeks later a new series was repeated. No patient was cured.

MeSH terms

  • Antimalarials / therapeutic use*
  • Humans
  • Leishmaniasis, Cutaneous / drug therapy*
  • Mefloquine / therapeutic use*

Substances

  • Antimalarials
  • Mefloquine